News Releases
May 24, 2021
Sangamo Therapeutics Appoints Prathyusha Duraibabu, CPA, MBA, to Chief Financial Officer
Additional Formats
May 21, 2021
Sangamo Therapeutics Announces Participation at Jefferies Healthcare Conference
Additional Formats
May 04, 2021
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
Additional Formats
May 03, 2021
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Additional Formats
Apr 27, 2021
Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene & Cell Therapy
Additional Formats
Apr 27, 2021
Sangamo Therapeutics Announces First Quarter 2021 Conference Call and Webcast
Additional Formats
Mar 25, 2021
Sangamo Therapeutics Announces Participation at Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease
Additional Formats
Mar 17, 2021
Sangamo Announces EMA Releases Details Supporting Orphan Designation for BIVV003 for the Treatment of Sickle Cell Disease
Additional Formats
Feb 24, 2021
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
Additional Formats
Feb 18, 2021
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Additional Formats
Displaying 1 - 10 of 14